Ipilimumab in Combination With Paclitaxel and Carboplatin in SCLCIpilimumab in Combination With Paclitaxel and Carboplatin in SCLC
This study enrolled patients with ED-SCLC as well as those with advanced NSCLC. Results for the ED-SCLC cohort are presented here. Annals of Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
More News: Cancer & Oncology | Health | Hematology | Non-Small Cell Lung Cancer | Small Cell Lung Cancer | Study | Yervoy